All are TRUE about the clinical features of polycythemia rubra vera, EXCEPT:
**Core Concept**
Polycythemia rubra vera (PRV) is a myeloproliferative disorder characterized by excessive production of red blood cells, white blood cells, and platelets. This leads to an increased hematocrit, which in turn causes hyperviscosity, thrombosis, and other clinical manifestations.
**Why the Correct Answer is Right**
The clinical features of PRV include **erythromelalgia**, a burning sensation in the hands and feet, **pruritus**, especially after taking a warm bath, and **splenomegaly**. These symptoms occur due to the increased viscosity of blood and the release of various cytokines and growth factors, such as erythropoietin and interleukin-6, which stimulate the proliferation of myeloid cells.
**Why Each Wrong Option is Incorrect**
* **Option A:** This option is incorrect because PRV is indeed associated with an increased risk of **thrombotic events**, including deep vein thrombosis and pulmonary embolism, due to the increased viscosity of blood and the presence of pro-coagulant factors.
* **Option B:** This option is incorrect because PRV is characterized by a **normal or elevated leukocyte count**, not a decreased count.
* **Option C:** This option is incorrect because PRV is associated with **splenomegaly**, not splenic atrophy.
**Clinical Pearl / High-Yield Fact**
It's essential to remember that PRV is a **myeloproliferative disorder**, and its diagnosis requires a combination of clinical features, laboratory findings, and bone marrow examination.
**Correct Answer:**
None of the options A, B, or C are correct statements about the clinical features of PRV, so the correct answer is not listed. However, the question asks for an exception, implying that one of the options is incorrect, so the best course of action is to choose one of the options that is most clearly incorrect, based on the information provided.